{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T05:30:50Z","timestamp":1792647050010,"version":"4.5.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2016,3,3]],"date-time":"2016-03-03T00:00:00Z","timestamp":1456963200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2016,3,3]],"date-time":"2016-03-03T00:00:00Z","timestamp":1456963200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["PCIG12\u2010GA\u20102012\u2010334259"],"award-info":[{"award-number":["PCIG12\u2010GA\u20102012\u2010334259"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","award":["FP7\/2007\u20132013"],"award-info":[{"award-number":["FP7\/2007\u20132013"]}],"id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","award":["321366"],"award-info":[{"award-number":["321366"]}],"id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["115372"],"award-info":[{"award-number":["115372"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007625","name":"Cure Alzheimer's Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007625","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000916","name":"MetLife Foundation Award","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000916","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001862","name":"Swedish Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001862","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007464","name":"Torsten S\u00f6derberg Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007464","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001725","name":"Royal Swedish Academy of Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004063","name":"Knut and Alice Wallenberg Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004063","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Frimurarestiftelsen","award":["115372"],"award-info":[{"award-number":["115372"]}]},{"name":"University Research Fund of the University of Antwerp"},{"DOI":"10.13039\/501100016171","name":"Institute Born\u2010Bunge","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100016171","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Foundation for Alzheimer Research"},{"DOI":"10.13039\/100017886","name":"Neurosearch Antwerp","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100017886","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003130","name":"Research Foundation\u2014Flanders","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Agency for Innovation by Science and Technology"},{"name":"Interuniversity Attraction Poles (IAP) Program of the Belgian Science Policy Office"},{"name":"Flemish Government Methusalem Excellence Program, Belgium"},{"name":"Flanders Impulse Program on Networks for Dementia Research"},{"name":"EU Joint Program for Neurodegenerative Disease Research","award":["321366"],"award-info":[{"award-number":["321366"]}]},{"name":"EU\/EFPIA Innovative Medicines Initiative Joint Undertaking","award":["115372"],"award-info":[{"award-number":["115372"]}]},{"name":"Belgian Science Policy Office Interuniversity Attraction Poles Program"},{"name":"Flanders Government Initiated Impulse Program on Networks for Dementia Research"},{"name":"Flemish government Initiated Methusalem Excellence Program"},{"name":"University of Antwerp Research Fund, Belgium"},{"name":"Janssen"},{"name":"ADx Neurosciences"},{"name":"Innogenetics\/Fujirebio Europe"},{"name":"Lundbeck"},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","award":["115372"],"award-info":[{"award-number":["115372"]}],"id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"name":"UCB"},{"DOI":"10.13039\/100016545","name":"Roche Diagnostics","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100016545","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Nutricia\/Danone","award":["115372"],"award-info":[{"award-number":["115372"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EMBO Mol Med"],"published-print":{"date-parts":[[2016,5,1]]},"DOI":"10.15252\/emmm.201506123","type":"journal-article","created":{"date-parts":[[2016,3,3]],"date-time":"2016-03-03T21:13:35Z","timestamp":1457039615000},"page":"466-476","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":512,"title":["sTREM2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early\u2010stage Alzheimer's disease and associate with neuronal injury markers"],"prefix":"10.1038","volume":"8","author":[{"given":"Marc","family":"Su\u00e1rez\u2010Calvet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gernot","family":"Kleinberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel \u00c1ngel","family":"Araque Caballero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Brendel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Axel","family":"Rominger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Alcolea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Fortea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Lle\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Blesa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Domingo","family":"Gispert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"S\u00e1nchez\u2010Valle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Antonell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorena","family":"Rami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 L","family":"Molinuevo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederic","family":"Brosseron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Trasch\u00fctz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael T","family":"Heneka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanne","family":"Struyfs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastiaan","family":"Engelborghs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristel","family":"Sleegers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Van Broeckhoven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Zetterberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bengt","family":"Nellg\u00e5rd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaj","family":"Blennow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Crispin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Ewers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Haass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,3,3]]},"reference":[{"key":"BFEMMM201506123_CR1","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jalz.2011.03.008","volume":"7","author":"MS Albert","year":"2011","unstructured":"Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, Gamst A, Holtzman DM, Jagust WJ, Petersen RC et\u00a0al (2011) The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging\u2010Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 7: 270\u2013279","journal-title":"Alzheimers Dement"},{"key":"BFEMMM201506123_CR2","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3233\/JAD-140240","volume":"42","author":"D Alcolea","year":"2014","unstructured":"Alcolea D, Carmona\u2010Iragui M, Su\u00e1rez\u2010Calvet M, S\u00e1nchez\u2010Saudin\u00f3s MB, Sala I, Ant\u00f3n\u2010Aguirre S, Blesa R, Clarim\u00f3n J, Fortea J, Lle\u00f3 A (2014) Relationship between \u03b2\u2010secretase, inflammation and core cerebrospinal fluid biomarkers for Alzheimer's disease. J Alzheimers Dis 42: 157\u2013167","journal-title":"J Alzheimers Dis"},{"key":"BFEMMM201506123_CR3","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s00702-010-0534-0","volume":"118","author":"A Antonell","year":"2011","unstructured":"Antonell A, Fortea J, Rami L, Bosch B, Balasa M, S\u00e1nchez\u2010Valle R, Iranzo A, Molinuevo JL, Llad\u00f3 A (2011) Different profiles of Alzheimer's disease cerebrospinal fluid biomarkers in controls and subjects with subjective memory complaints. J Neural Transm 118: 259\u2013262","journal-title":"J Neural Transm"},{"key":"BFEMMM201506123_CR4","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/nrneurol.2010.4","volume":"6","author":"K Blennow","year":"2010","unstructured":"Blennow K, Hampel H, Weiner M, Zetterberg H (2010) Cerebrospinal fluid and plasma biomarkers in Alzheimer disease. Nat Rev Neurol 6: 131\u2013144","journal-title":"Nat Rev Neurol"},{"key":"BFEMMM201506123_CR5","doi-asserted-by":"crossref","first-page":"934.e7","DOI":"10.1016\/j.neurobiolaging.2013.09.017","volume":"35","author":"B Borroni","year":"2013","unstructured":"Borroni B, Ferrari F, Galimberti D, Nacmias B, Barone C, Bagnoli S, Fenoglio C, Piaceri I, Archetti S, Bonvicini C et\u00a0al (2013) Heterozygous TREM2 mutations in frontotemporal dementia. Neurobiol Aging 35: 934.e7\u2013e10","journal-title":"Neurobiol Aging"},{"key":"BFEMMM201506123_CR6","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1084\/jem.194.8.1111","volume":"194","author":"A Bouchon","year":"2001","unstructured":"Bouchon A, Hern\u00e1ndez\u2010Munain C, Cella M, Colonna M (2001) A DAP12\u2010mediated pathway regulates expression of CC chemokine receptor 7 and maturation of human dendritic cells. J Exp Med 194: 1111\u20131122","journal-title":"J Exp Med"},{"key":"BFEMMM201506123_CR7","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0197-4580(97)00056-0","volume":"18","author":"H Braak","year":"1997","unstructured":"Braak H, Braak E (1997) Frequency of stages of Alzheimer\u2010related lesions in different age categories. Neurobiol Aging 18: 351\u2013357","journal-title":"Neurobiol Aging"},{"key":"BFEMMM201506123_CR8","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1007\/s12035-014-8657-1","volume":"50","author":"F Brosseron","year":"2014","unstructured":"Brosseron F, Krauthausen M, Kummer M, Heneka MT (2014) Body fluid cytokine levels in mild cognitive impairment and Alzheimer's disease: a comparative overview. Mol Neurobiol 50: 534\u2013544","journal-title":"Mol Neurobiol"},{"key":"BFEMMM201506123_CR9","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1001\/archneur.60.12.1696","volume":"60","author":"CM Clark","year":"2003","unstructured":"Clark CM, Xie S, Chittams J, Ewbank D, Peskind E, Galasko D, Morris JC, McKeel DW, Farlow M, Weitlauf SL et\u00a0al (2003) Cerebrospinal fluid tau and beta\u2010amyloid: how well do these biomarkers reflect autopsy\u2010confirmed dementia diagnoses? Arch Neurol 60: 1696\u20131702","journal-title":"Arch Neurol"},{"key":"BFEMMM201506123_CR10","doi-asserted-by":"crossref","first-page":"e18850","DOI":"10.1371\/journal.pone.0018850","volume":"6","author":"R Craig\u2010Schapiro","year":"2011","unstructured":"Craig\u2010Schapiro R, Kuhn M, Xiong C, Pickering EH, Liu J, Misko TP, Perrin RJ, Bales KR, Soares H, Fagan AM et\u00a0al (2011) Multiplexed immunoassay panel identifies novel CSF biomarkers for Alzheimer's disease diagnosis and prognosis. PLoS ONE 6: e18850","journal-title":"PLoS ONE"},{"key":"BFEMMM201506123_CR11","doi-asserted-by":"crossref","first-page":"726.e11","DOI":"10.1016\/j.neurobiolaging.2013.09.009","volume":"35","author":"E Cuyvers","year":"2014","unstructured":"Cuyvers E, Bettens K, Philtjens S, Van Langenhove T, Gijselinck I, van der Zee J, Engelborghs S, Vandenbulcke M, Van Dongen J, Geerts N et\u00a0al (2014) Investigating the role of rare heterozygous TREM2 variants in Alzheimer's disease and frontotemporal dementia. Neurobiol Aging 35: 726.e11\u2013e19","journal-title":"Neurobiol Aging"},{"key":"BFEMMM201506123_CR12","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1016\/j.neurobiolaging.2005.10.007","volume":"27","author":"D Galimberti","year":"2006","unstructured":"Galimberti D, Fenoglio C, Lovati C, Venturelli E, Guidi I, Corr\u00e0 B, Scalabrini D, Clerici F, Mariani C, Bresolin N et\u00a0al (2006a) Serum MCP\u20101 levels are increased in mild cognitive impairment and mild Alzheimer's disease. Neurobiol Aging 27: 1763\u20131768","journal-title":"Neurobiol Aging"},{"key":"BFEMMM201506123_CR13","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1001\/archneur.63.4.538","volume":"63","author":"D Galimberti","year":"2006","unstructured":"Galimberti D, Schoonenboom N, Scheltens P, Fenoglio C, Bouwman F, Venturelli E, Guidi I, Blankenstein MA, Bresolin N, Scarpini E (2006b) Intrathecal chemokine synthesis in mild cognitive impairment and Alzheimer disease. Arch Neurol 63: 538\u2013543","journal-title":"Arch Neurol"},{"key":"BFEMMM201506123_CR14","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1056\/NEJMoa1211851","volume":"368","author":"R Guerreiro","year":"2013","unstructured":"Guerreiro R, Wojtas A, Bras J, Carrasquillo M, Rogaeva E, Majounie E, Cruchaga C, Sassi C, Kauwe JS, Younkin S et\u00a0al (2013a) TREM2 variants in Alzheimer's disease. N Engl J Med 368: 117\u2013127","journal-title":"N Engl J Med"},{"key":"BFEMMM201506123_CR15","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1001\/jamaneurol.2013.579","volume":"70","author":"RJ Guerreiro","year":"2013","unstructured":"Guerreiro RJ, Lohmann E, Br\u00e1s JM, Gibbs JR, Rohrer JD, Gurunlian N, Dursun B, Bilgic B, Hanagasi H, Gurvit H et\u00a0al (2013b) Using exome sequencing to reveal mutations in TREM2 presenting as a frontotemporal dementia\u2010like syndrome without bone involvement. JAMA Neurol 70: 78\u201384","journal-title":"JAMA Neurol"},{"key":"BFEMMM201506123_CR16","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","volume":"14","author":"MT Heneka","year":"2015","unstructured":"Heneka MT, Carson MJ, El Khoury J, Landreth GE, Brosseron F, Feinstein DL, Jacobs AH, Wyss\u2010Coray T, Vitorica J, Ransohoff RM et\u00a0al (2015) Neuroinflammation in Alzheimer's disease. Lancet Neurol 14: 388\u2013405","journal-title":"Lancet Neurol"},{"key":"BFEMMM201506123_CR17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13024-016-0071-x","volume":"11","author":"A Heslegrave","year":"2016","unstructured":"Heslegrave A, Heywood W, Paterson R, Magdalinou N, Svensson J, Johansson P, \u00d6hrfelt A, Blennow K, Hardy J, Schott J et\u00a0al (2016) Increased cerebrospinal fluid soluble TREM2 concentration in Alzheimer's disease. Mol Neurodegener 11: 1\u20137","journal-title":"Mol Neurodegener"},{"key":"BFEMMM201506123_CR18","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1111\/j.1471-4159.2009.06042.x","volume":"109","author":"CL Hsieh","year":"2009","unstructured":"Hsieh CL, Koike M, Spusta SC, Niemi EC, Yenari M, Nakamura MC, Seaman WE (2009) A role for TREM2 ligands in the phagocytosis of apoptotic neuronal cells by microglia. J Neurochem 109: 1144\u20131156","journal-title":"J Neurochem"},{"key":"BFEMMM201506123_CR19","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1097\/00005072-199812000-00009","volume":"57","author":"CM Hulette","year":"1998","unstructured":"Hulette CM, Welsh\u2010Bohmer KA, Murray MG, Saunders AM, Mash DC, McIntyre LM (1998) Neuropathological and neuropsychological changes in \u2018normal\u2019 aging: evidence for preclinical Alzheimer disease in cognitively normal individuals. J Neuropathol Exp Neurol 57: 1168\u20131174","journal-title":"J Neuropathol Exp Neurol"},{"key":"BFEMMM201506123_CR20","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1002\/ana.22628","volume":"71","author":"CR Jack","year":"2012","unstructured":"Jack CR, Knopman DS, Weigand SD, Wiste HJ, Vemuri P, Lowe V, Kantarci K, Gunter JL, Senjem ML, Ivnik RJ et\u00a0al (2012) An operational approach to National Institute on Aging\u2010Alzheimer's Association criteria for preclinical Alzheimer disease. Ann Neurol 71: 765\u2013775","journal-title":"Ann Neurol"},{"key":"BFEMMM201506123_CR21","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1084\/jem.2121insight1","volume":"212","author":"TR Jay","year":"2015","unstructured":"Jay TR, Miller CM, Cheng PJ, Graham LC, Bemiller S, Broihier ML, Xu G, Margevicius D, Karlo JC, Sousa GL et\u00a0al (2015) TREM2 deficiency eliminates TREM2 + inflammatory macrophages and ameliorates pathology in Alzheimer's disease mouse models. J Exp Med 212: 2\u201310","journal-title":"J Exp Med"},{"key":"BFEMMM201506123_CR22","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1056\/NEJMoa1211103","volume":"368","author":"T Jonsson","year":"2013","unstructured":"Jonsson T, Stefansson H, Steinberg S, Jonsdottir I, Jonsson PV, Snaedal J, Bjornsson S, Huttenlocher J, Levey AI, Lah JJ et\u00a0al (2013) Variant of TREM2 associated with the risk of Alzheimer's disease. N Engl J Med 368: 107\u2013116","journal-title":"N Engl J Med"},{"key":"BFEMMM201506123_CR23","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.nbd.2004.09.007","volume":"18","author":"A Kiialainen","year":"2005","unstructured":"Kiialainen A, Hovanes K, Paloneva J, Kopra O, Peltonen L (2005) Dap12 and Trem2, molecules involved in innate immunity and neurodegeneration, are co\u2010expressed in the CNS. Neurobiol Dis 18: 314\u2013322","journal-title":"Neurobiol Dis"},{"key":"BFEMMM201506123_CR24","doi-asserted-by":"crossref","first-page":"243ra86","DOI":"10.1126\/scitranslmed.3009093","volume":"6","author":"G Kleinberger","year":"2014","unstructured":"Kleinberger G, Yamanishi Y, Su\u00e1rez\u2010Calvet M, Czirr E, Lohmann E, Cuyvers E, Struyfs H, Pettkus N, Wenninger\u2010Weinzierl A, Mazaheri F et\u00a0al (2014) TREM2 mutations implicated in neurodegeneration impair cell surface transport and phagocytosis. Sci Transl Med 6: 243ra86","journal-title":"Sci Transl Med"},{"key":"BFEMMM201506123_CR25","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1038\/ni1411","volume":"7","author":"J Klesney\u2010Tait","year":"2006","unstructured":"Klesney\u2010Tait J, Turnbull IR, Colonna M (2006) The TREM receptor family and signal integration. Nat Immunol 7: 1266\u20131273","journal-title":"Nat Immunol"},{"key":"BFEMMM201506123_CR26","doi-asserted-by":"crossref","first-page":"15716","DOI":"10.1523\/JNEUROSCI.0996-15.2015","volume":"35","author":"B Liu","year":"2015","unstructured":"Liu B, Le KX, Park MA, Wang S, Belanger AP, Dubey S, Frost JL, Holton P, Reiser V, Jones PA et\u00a0al (2015) In vivo detection of age\u2010 and disease\u2010related increases in neuroinflammation by 18F\u2010GE180 TSPO microPET Imaging in wild\u2010type and Alzheimer's transgenic mice. J Neurosci 35: 15716\u201315730","journal-title":"J Neurosci"},{"key":"BFEMMM201506123_CR27","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.celrep.2014.12.041","volume":"10","author":"M Matarin","year":"2015","unstructured":"Matarin M, Salih DA, Yasvoina M, Cummings DM, Guelfi S, Liu W, Nahaboo Solim MA, Moens TG, Paublete RM, Ali SS et\u00a0al (2015) A genome\u2010wide gene\u2010expression analysis and database in transgenic mice during development of amyloid or tau pathology. Cell Rep 10: 633\u2013644","journal-title":"Cell Rep"},{"key":"BFEMMM201506123_CR28","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.jalz.2011.05.2243","volume":"7","author":"N Mattsson","year":"2011","unstructured":"Mattsson N, Andreasson U, Persson S, Arai H, Batish SD, Bernardini S, Bocchio\u2010Chiavetto L, Blankenstein MA, Carrillo MC, Chalbot S et\u00a0al (2011) The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers. Alzheimers Dement 7: 386\u2013395.e6","journal-title":"Alzheimers Dement"},{"key":"BFEMMM201506123_CR29","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","volume":"7","author":"GM McKhann","year":"2011","unstructured":"McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR, Kawas CH, Klunk WE, Koroshetz WJ, Manly JJ, Mayeux R et\u00a0al (2011) The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging\u2010Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 7: 263\u2013269","journal-title":"Alzheimers Dement"},{"key":"BFEMMM201506123_CR30","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.jalz.2014.03.003","volume":"10","author":"JL Molinuevo","year":"2014","unstructured":"Molinuevo JL, Blennow K, Dubois B, Engelborghs S, Lewczuk P, Perret\u2010Liaudet A, Teunissen CE, Parnetti L (2014) The clinical use of cerebrospinal fluid biomarker testing for Alzheimer's disease diagnosis: a consensus paper from the Alzheimer's Biomarkers Standardization Initiative. Alzheimers Dement 10: 808\u2013817","journal-title":"Alzheimers Dement"},{"key":"BFEMMM201506123_CR31","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1212\/WNL.46.3.707","volume":"46","author":"JC Morris","year":"1996","unstructured":"Morris JC, Storandt M, McKeel DW, Rubin EH, Price JL, Grant EA, Berg L (1996) Cerebral amyloid deposition and diffuse plaques in \u2018normal\u2019 aging: evidence for presymptomatic and very mild Alzheimer's disease. Neurology 46: 707\u2013719","journal-title":"Neurology"},{"key":"BFEMMM201506123_CR32","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.bcp.2014.01.008","volume":"88","author":"KI Mosher","year":"2014","unstructured":"Mosher KI, Wyss\u2010Coray T (2014) Microglial dysfunction in brain aging and Alzheimer's disease. Biochem Pharmacol 88: 594\u2013604","journal-title":"Biochem Pharmacol"},{"key":"BFEMMM201506123_CR33","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.imlet.2007.09.002","volume":"114","author":"M Motta","year":"2007","unstructured":"Motta M, Imbesi R, Di Rosa M, Stivala F, Malaguarnera L (2007) Altered plasma cytokine levels in Alzheimer's disease: correlation with the disease progression. Immunol Lett 114: 46\u201351","journal-title":"Immunol Lett"},{"key":"BFEMMM201506123_CR34","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1086\/342259","volume":"71","author":"J Paloneva","year":"2002","unstructured":"Paloneva J, Manninen T, Christman G, Hovanes K, Mandelin J, Adolfsson R, Bianchin M, Bird T, Miranda R, Salmaggi A et\u00a0al (2002) Mutations in two genes encoding different subunits of a receptor signaling complex result in an identical disease phenotype. Am J Hum Genet 71: 656\u2013662","journal-title":"Am J Hum Genet"},{"key":"BFEMMM201506123_CR35","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1084\/jem.20030027","volume":"198","author":"J Paloneva","year":"2003","unstructured":"Paloneva J, Mandelin J, Kiialainen A, Bohling T, Prudlo J, Hakola P, Haltia M, Konttinen YT, Peltonen L (2003) DAP12\/TREM2 deficiency results in impaired osteoclast differentiation and osteoporotic features. J Exp Med 198: 669\u2013675","journal-title":"J Exp Med"},{"key":"BFEMMM201506123_CR36","doi-asserted-by":"crossref","first-page":"3081","DOI":"10.1093\/brain\/awn217","volume":"131","author":"L Piccio","year":"2008","unstructured":"Piccio L, Buonsanti C, Cella M, Tassi I, Schmidt RE, Fenoglio C, Rinker J, Naismith RT, Panina\u2010Bordignon P, Passini N et\u00a0al (2008) Identification of soluble TREM\u20102 in the cerebrospinal fluid and its association with multiple sclerosis and CNS inflammation. Brain 131: 3081\u20133091","journal-title":"Brain"},{"key":"BFEMMM201506123_CR37","doi-asserted-by":"publisher","unstructured":"Piccio L, Deming Y, Del\u2010\u00c1guila JL, Ghezzi L, Holtzman DM, Fagan AM, Fenoglio C, Galimberti D, Borroni B, Cruchaga C (2016) Cerebrospinal fluid soluble TREM2 is higher in Alzheimer disease and associated with mutation status. Acta Neuropathol doi:https:\/\/doi.org\/10.1007\/s00401\u2010016\u20101533\u20105","DOI":"10.1007\/s00401-016-1533-5"},{"key":"BFEMMM201506123_CR38","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/1531-8249(199903)45:3<358::AID-ANA12>3.0.CO;2-X","volume":"45","author":"JL Price","year":"1999","unstructured":"Price JL, Morris JC (1999) Tangles and plaques in nondemented aging and \u2018preclinical\u2019 Alzheimer's disease. Ann Neurol 45: 358\u2013368","journal-title":"Ann Neurol"},{"key":"BFEMMM201506123_CR39","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1750-1326-8-19","volume":"8","author":"S Rayaprolu","year":"2013","unstructured":"Rayaprolu S, Mullen B, Baker M, Lynch T, Finger E, Seeley WW, Hatanpaa KJ, Lomen\u2010Hoerth C, Kertesz A, Bigio EH et\u00a0al (2013) TREM2 in neurodegeneration: evidence for association of the p. R47H variant with frontotemporal dementia and Parkinson's disease. Mol Neurodegener 8: 19","journal-title":"Mol Neurodegener"},{"key":"BFEMMM201506123_CR40","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1046\/j.1471-4159.2002.01243.x","volume":"83","author":"CD Schmid","year":"2002","unstructured":"Schmid CD, Sautkulis LN, Danielson PE, Cooper J, Hasel KW, Hilbush BS, Sutcliffe JG, Carson MJ (2002) Heterogeneous expression of the triggering receptor expressed on myeloid cells\u20102 on adult murine microglia. J Neurochem 83: 1309\u20131320","journal-title":"J Neurochem"},{"key":"BFEMMM201506123_CR41","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/ana.21610","volume":"65","author":"LM Shaw","year":"2009","unstructured":"Shaw LM, Vanderstichele H, Knapik\u2010Czajka M, Clark CM, Aisen PS, Petersen RC, Blennow K, Soares H, Simon A, Lewczuk P et\u00a0al (2009) Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects. Ann Neurol 65: 403\u2013413","journal-title":"Ann Neurol"},{"key":"BFEMMM201506123_CR42","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jalz.2011.03.003","volume":"7","author":"RA Sperling","year":"2011","unstructured":"Sperling RA, Aisen PS, Beckett LA, Bennett DA, Craft S, Fagan AM, Iwatsubo T, Jack CR, Kaye J, Montine TJ et\u00a0al (2011) Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging\u2010Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 7: 280\u2013292","journal-title":"Alzheimers Dement"},{"key":"BFEMMM201506123_CR43","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s40478-014-0142-6","volume":"2","author":"WJ Streit","year":"2014","unstructured":"Streit WJ, Xue QS, Tischer J, Bechmann I (2014) Microglial pathology. Acta Neuropathol Commun 2: 142","journal-title":"Acta Neuropathol Commun"},{"key":"BFEMMM201506123_CR44","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1084\/jem.20041611","volume":"201","author":"K Takahashi","year":"2005","unstructured":"Takahashi K, Rochford CD, Neumann H (2005) Clearance of apoptotic neurons without inflammation by microglial triggering receptor expressed on myeloid cells\u20102. J Exp Med 201: 647\u2013657","journal-title":"J Exp Med"},{"key":"BFEMMM201506123_CR45","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.1056\/NEJMcibr1503954","volume":"372","author":"RE Tanzi","year":"2015","unstructured":"Tanzi RE (2015) TREM2 and risk of Alzheimer's disease \u2014 friend or foe? N Engl J Med 372: 2564\u20132565","journal-title":"N Engl J Med"},{"key":"BFEMMM201506123_CR46","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.3233\/JAD-140405","volume":"42","author":"S Van der Mussele","year":"2014","unstructured":"Van der Mussele S, Fransen E, Struyfs H, Luyckx J, Mari\u00ebn P, Saerens J, Somers N, Goeman J, De Deyn PP, Engelborghs S (2014) Depression in\u00a0mild cognitive impairment is associated with progression to Alzheimer's disease: a longitudinal study. J Alzheimers Dis 42: 1239\u20131250","journal-title":"J Alzheimers Dis"},{"key":"BFEMMM201506123_CR47","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jalz.2011.07.004","volume":"8","author":"H Vanderstichele","year":"2012","unstructured":"Vanderstichele H, Bibl M, Engelborghs S, Le Bastard N, Lewczuk P, Molinuevo JL, Parnetti L, Perret\u2010Liaudet A, Shaw LM, Teunissen C et\u00a0al (2012) Standardization of preanalytical aspects of cerebrospinal fluid biomarker testing for Alzheimer's disease diagnosis: a consensus paper from the Alzheimer's Biomarkers Standardization Initiative. Alzheimers Dement 8: 65\u201373","journal-title":"Alzheimers Dement"},{"key":"BFEMMM201506123_CR48","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.cell.2015.01.049","volume":"160","author":"Y Wang","year":"2015","unstructured":"Wang Y, Cella M, Mallinson K, Ulrich JD, Young KL, Robinette ML, Gilfillan S, Krishnan GM, Sudhakar S, Zinselmeyer BH et\u00a0al (2015) TREM2 lipid sensing sustains the microglial response in an Alzheimer's disease model. Cell 160: 1061\u20131071","journal-title":"Cell"},{"key":"BFEMMM201506123_CR49","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1365-2796.2004.01380.x","volume":"256","author":"B Winblad","year":"2004","unstructured":"Winblad B, Palmer K, Kivipelto M, Jelic V, Fratiglioni L, Wahlund L, Nordberg A, B\u00e4ckman L, Albert M, Almkvist O et\u00a0al (2004) Mild cognitive impairment\u2013beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. J Intern Med 256: 240\u2013246","journal-title":"J Intern Med"},{"key":"BFEMMM201506123_CR50","doi-asserted-by":"crossref","first-page":"33027","DOI":"10.1074\/jbc.M113.517540","volume":"288","author":"P Wunderlich","year":"2013","unstructured":"Wunderlich P, Glebov K, Kemmerling N, Tien NT, Neumann H, Walter J (2013) Sequential proteolytic processing of the triggering receptor expressed on myeloid cells\u20102 (TREM2) protein by ectodomain shedding and \u03b3\u2010secretase\u2010dependent intramembranous cleavage. J Biol Chem 288: 33027\u201333036","journal-title":"J Biol Chem"}],"container-title":["EMBO Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.15252\/emmm.201506123.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.15252\/emmm.201506123","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.15252\/emmm.201506123\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.embopress.org\/doi\/pdf\/10.15252\/emmm.201506123","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.15252\/emmm.201506123.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T06:14:14Z","timestamp":1779084854000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.15252\/emmm.201506123"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,3]]},"references-count":50,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,5,1]]}},"alternative-id":["BFEMMM201506123"],"URL":"https:\/\/doi.org\/10.15252\/emmm.201506123","relation":{},"ISSN":["1757-4676","1757-4684"],"issn-type":[{"value":"1757-4676","type":"print"},{"value":"1757-4684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,3]]},"assertion":[{"value":"3 December 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2016","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2016","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2016","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Sebastiaan Engelborghs is consultant for and received research funding from Janssen, ADx Neurosciences, Innogenetics\/Fujirebio Europe, Lundbeck, Pfizer, Novartis, UCB, Roche Diagnostics, Nutricia\/Danone. The remaining authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}